Mrfr has published detailed analysis on “Women Healthcare Market”
Market Analysis:
The global women healthcare market is predicted to grow at a
5.04% CAGR between 2017-2023, reveals the latest Market Research Future (MRFR)
report. Women's health, simply put, is a branch of medicine which focuses on
the diagnosis and treatment of conditions and diseases which affect the
emotional and physical well-being of a woman. It includes a huge range of focus
areas and specialties such as gynecology, sexually transmitted infections,
birth control, ovarian cancer, breast cancer and other types of female cancers,
sexual health, childbirth and pregnancy, osteoporosis, hormone therapy and
menopause, mammography, and benign conditions that affect the functioning of
female reproductive organs.
Also Read:
Various factors are propelling the Global Women’s
Healthcare Market Report . These factors, as per
the new Market Research Future (MRFR) report, include increasing geriatric
women population, increasing adoption of unhealthy lifestyle, launch of new
medicines for women, favorable policies undertaken by the government for
raising awareness and improving women’s health, and rising incidence of
obesity, depression, menstrual health-related disorders, anemia,
osteoarthritis, and osteoporosis. Additional factors propelling market growth
include technological advancements, increasing women’s health issues, change in
government regulations, and investment made by market players for commercialization
and research and development.
Key Players:
Teva Pharmaceuticals
(Israel), Pfizer Inc., (US), Merck & Co., Inc., (US), Eli Lilly Company
(US), Becton Dickinson and Company (US), Bayer AG (Germany), Amgen
(California), and Allergan plc. (Ireland).
Market Segmentation:
·
The MRFR report provides an all-inclusive segmental analysis of
the Women Healthcare
Market on the basis of diagnosis, treatment, indications, and end users.
·
Based on indication, the women healthcare market is segmented
into gynecologic cancer, polycystic ovary syndrome, reproductive health
management, infertility, postmenopausal osteoporosis, and others. The
gynecologic cancer segment is again segmented into ovarian, breast, and other
forms of cancer. Of these, the postmenopausal osteoporosis segment will have
the largest share in the market over the forecast period. Factors pushing the
growth of the segment include the presence of several key players, ongoing
R&D activities, the launch of new drugs to treat menopausal osteoporosis,
and the rise in the female population aged 40 and above.
·
Based on diagnosis, the global women healthcare market is
segmented into biopsies, ovulation testing, diagnostic imaging tests, bone
densitometry, and others.
·
Based on treatment, the women healthcare market is segmented
into surgeries, therapeutics, and others.
·
Based on end users, the women healthcare market is segmented
into research institutes, gynecology centers, hospitals and clinics, and
others. Among these, hospitals and clinics will dominate the market over the
forecast period as a higher proportion of female patients visit hospitals and
clinics both for diagnosis as well as treatment of different health issues.
Regional Analysis:
By region, the women healthcare market report covers the latest
trends and growth opportunities across Europe, North America, the Asia Pacific
(APAC), and the Middle East and Africa (MEA). Of these, North America will
spearhead the market over the forecast period and is predicted to touch USD 21,
782.6 million by 2023. Factors pushing growth in this region include the
presence of a well-developed economy, favorable initiatives undertaken for
promoting women healthcare, the presence of several key market players,
favorable reimbursement, commercialization and approval of products, and
increasing awareness regarding women’s health.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/women-Healthcare-market-3121
The women healthcare market in the APAC region is predicted to
grow at the fastest pace over the forecast period. Factors propelling growth in
the region include increasing incidence of infertility, osteoarthritis, and
other forms of women-related health problems due to stress, growing awareness
about women’s health, and initiatives undertaken by the government for raising
awareness and reimbursement.
The women healthcare market in Europe is predicted to have a
favorable growth over the forecast period while that in the MEA is likely to
have limited growth over the forecast period chiefly due to the high price of
diagnosis and treatment.
Industry News
Oct 2019: Qure4u, a renowned patient engagement solution
provider, has joined hands with Unified Women’s Healthcare, a leading
multi-state organization that is dedicated to advance the transformation of
female healthcare in the US. Qure4u’s digital engagement tool will better help
Unified-affiliated Ob-Gyn providers, especially when engaging with patients.
Related Infographics Links:
Duloxetine API
Market Research Report - Global Forecast till 2023
https://www.marketresearchfuture.com/infographics/duloxetine-api-market
Decorative High-Pressure Laminates
Market Research Report—Forecast till 2023
https://www.marketresearchfuture.com/infographics/decorative-high-pressure-laminates-market
Related Videos:
Cell Therapy Market
Insights 2019-2023
https://www.marketresearchfuture.com/videos/cell-therapy-market
No comments:
Post a Comment